Zannella, C.; Rinaldi, L.; Boccia, G.; Chianese, A.; Sasso, F.C.; De Caro, F.; Franci, G.; Galdiero, M.
Regulation of m6A Methylation as a New Therapeutic Option against COVID-19. Pharmaceuticals 2021, 14, 1135.
https://doi.org/10.3390/ph14111135
AMA Style
Zannella C, Rinaldi L, Boccia G, Chianese A, Sasso FC, De Caro F, Franci G, Galdiero M.
Regulation of m6A Methylation as a New Therapeutic Option against COVID-19. Pharmaceuticals. 2021; 14(11):1135.
https://doi.org/10.3390/ph14111135
Chicago/Turabian Style
Zannella, Carla, Luca Rinaldi, Giovanni Boccia, Annalisa Chianese, Ferdinando Carlo Sasso, Francesco De Caro, Gianluigi Franci, and Massimiliano Galdiero.
2021. "Regulation of m6A Methylation as a New Therapeutic Option against COVID-19" Pharmaceuticals 14, no. 11: 1135.
https://doi.org/10.3390/ph14111135
APA Style
Zannella, C., Rinaldi, L., Boccia, G., Chianese, A., Sasso, F. C., De Caro, F., Franci, G., & Galdiero, M.
(2021). Regulation of m6A Methylation as a New Therapeutic Option against COVID-19. Pharmaceuticals, 14(11), 1135.
https://doi.org/10.3390/ph14111135